Have a feature idea you'd love to see implemented?
Let us know!
SAVA Cassava Sciences Inc
Price (delayed)
$27.29
Market cap
$1.31B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.4
Enterprise value
$1.1B
Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to
Highlights
Cassava Sciences's equity has soared by 140% from the previous quarter and by 5% YoY
The net income has soared by 83% YoY and by 68% from the previous quarter
The quick ratio has soared by 136% since the previous quarter but it has dropped by 60% year-on-year
Key stats
What are the main financial stats of SAVA
Market
Valuations
Earnings
Shares outstanding
47.98M
Market cap
$1.31B
Enterprise value
$1.1B
Price to earnings (P/E)
N/A
Price to book (P/B)
6.93
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$15.37M
EBITDA
-$14.01M
Free cash flow
-$86.31M
Per share
Balance sheet
Liquidity
EPS
-$0.4
Free cash flow per share
-$1.87
Book value per share
$3.94
Revenue per share
$0
TBVPS
$5.27
Total assets
$243.57M
Total liabilities
$54.59M
Debt
$0
Equity
$188.97M
Working capital
$167.53M
Debt to equity
0
Current ratio
4.07
Quick ratio
3.8
Net debt/EBITDA
14.79
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-8.5%
Return on equity
-11%
Return on invested capital
N/A
Return on capital employed
-8.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SAVA stock price
How has the Cassava Sciences stock price performed over time
Intraday
-2.5%
1 week
-7.73%
1 month
-7.74%
1 year
84.77%
YTD
21.24%
QTD
-7.27%
Financial performance
How have Cassava Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$132M
Net income
-$15.37M
Gross margin
N/A
Net margin
N/A
The net income has soared by 83% YoY and by 68% from the previous quarter
Cassava Sciences's operating income has decreased by 35% YoY and by 33% from the previous quarter
Growth
What is Cassava Sciences's growth rate over time
Valuation
What is Cassava Sciences stock price valuation
P/E
N/A
P/B
6.93
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Cassava Sciences's EPS has soared by 82% YoY and by 66% from the previous quarter
Cassava Sciences's equity has soared by 140% from the previous quarter and by 5% YoY
SAVA's P/B is 8% above its 5-year quarterly average of 6.4 and 8% above its last 4 quarters average of 6.4
Efficiency
How efficient is Cassava Sciences business performance
Cassava Sciences's ROA has soared by 80% YoY and by 70% from the previous quarter
SAVA's return on equity has surged by 75% year-on-year and by 68% since the previous quarter
Dividends
What is SAVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SAVA.
Financial health
How did Cassava Sciences financials performed over time
The quick ratio has soared by 136% since the previous quarter but it has dropped by 60% year-on-year
The current ratio has soared by 134% from the previous quarter but it has plunged by 58% YoY
Cassava Sciences's debt is 100% less than its equity
Cassava Sciences's equity has soared by 140% from the previous quarter and by 5% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.